A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer
Developmental Cell · 2025
DOI: 10.1016/j.devcel.2025.11.005 ↗At a glance
Kommentar in Developmental Cell, 2025. Written by Carmine Settembre. Institution: Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, It…. Major MEDLINE topics: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Endoplasmic Reticulum, Proto-Oncogene Proteins p21(ras). 10 references. Funded by: European Research Council.
Abstract (original language)
KRAS mutations drive pancreatic ductal adenocarcinoma (PDAC). In this issue of Developmental Cell, Salomó Coll et al.1 reveal that KRAS suppresses endoplasmic reticulum (ER)-phagy in pancreatic acinar cells by inhibiting CCPG1 transcription. Impaired ER-phagy triggers protein aggregation, inflammation, and acinar-to-ductal metaplasia, promoting tumorigenesis. These findings highlight selective autophagy's role in cancer, with possible therapeutic implications.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. Electronic address: settembre@tigem.it.
Funding
- European Research Council
Cite
APA
Settembre, C. (2025). A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.11.005
Vancouver
Settembre C. A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.11.005
BibTeX
@article{Settembre2025,
author = {Settembre, Carmine},
title = {A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer},
journal = {Developmental Cell},
year = {2025},
doi = {10.1016/j.devcel.2025.11.005}
}
EUVIMED